{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T21:44:42Z","timestamp":1790631882686,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T00:00:00Z","timestamp":1696809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1007\/s00210-023-02733-w","type":"journal-article","created":{"date-parts":[[2023,10,9]],"date-time":"2023-10-09T05:15:09Z","timestamp":1696828509000},"page":"2257-2267","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Ursolic acid attenuates cholestasis through NRF2-mediated regulation of UGT2B7 and BSEP\/MRP2"],"prefix":"10.1007","volume":"397","author":[{"given":"Xing","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqiang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liying","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maolian","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuqing","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyi","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaosong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,9]]},"reference":[{"key":"2733_CR1","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1002\/iub.2066","volume":"71","author":"GJ AlekhyaSita","year":"2019","unstructured":"AlekhyaSita GJ, Gowthami M, Srikanth G et al (2019) Protective role of luteolin against bisphenol A-induced renal toxicity through suppressing oxidative stress, inflammation, and upregulating Nrf2\/ARE\/ HO-1 pathway. IUBMB Life 71:1041\u20131047. https:\/\/doi.org\/10.1002\/iub.2066","journal-title":"IUBMB Life"},{"key":"2733_CR2","doi-asserted-by":"publisher","unstructured":"Arzumanian VA, Kiseleva OI, Poverennaya EV (2021) The curious case of the HepG2 cell line: 40 years of expertise. Int J Mol Sci 22. https:\/\/doi.org\/10.3390\/ijms222313135","DOI":"10.3390\/ijms222313135"},{"key":"2733_CR3","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.ejphar.2015.08.029","volume":"765","author":"P Chen","year":"2015","unstructured":"Chen P, Li J, Fan X et al (2015) Oleanolic acid attenuates obstructive cholestasis in bile duct-ligated mice, possibly via activation of NRF2-MRPs and FXR antagonism. Eur J Pharmacol 765:131\u2013139. https:\/\/doi.org\/10.1016\/j.ejphar.2015.08.029","journal-title":"Eur J Pharmacol"},{"key":"2733_CR4","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1002\/bdd.2011","volume":"37","author":"Y Cheng","year":"2016","unstructured":"Cheng Y, Freeden C, Zhang Y et al (2016) Biliary excretion of pravastatin and taurocholate in rats with bile salt export pump (Bsep) impairment. Biopharm Drug Dispos 37:276\u2013286. https:\/\/doi.org\/10.1002\/bdd.2011","journal-title":"Biopharm Drug Dispos"},{"key":"2733_CR5","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.ejphar.2008.06.044","volume":"590","author":"Y Ding","year":"2008","unstructured":"Ding Y, Zhao L, Mei H et al (2008) Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur J Pharmacol 590:377\u2013386. https:\/\/doi.org\/10.1016\/j.ejphar.2008.06.044","journal-title":"Eur J Pharmacol"},{"key":"2733_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2022.121343","volume":"314","author":"MA Fawzy","year":"2023","unstructured":"Fawzy MA, Nasr G, Ali FEM et al (2023) Quercetin potentiates the hepatoprotective effect of sildenafil and\/or pentoxifylline against intrahepatic cholestasis: role of Nrf2\/ARE, TLR4\/NF-kappaB, and NLRP3\/IL-1beta signaling pathways. Life Sci 314:121343. https:\/\/doi.org\/10.1016\/j.lfs.2022.121343","journal-title":"Life Sci"},{"key":"2733_CR7","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.jhep.2019.04.001","volume":"71","author":"MH Harms","year":"2019","unstructured":"Harms MH, van Buuren HR, Corpechot C et al (2019) Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitis. J Hepatol 71:357\u2013365. https:\/\/doi.org\/10.1016\/j.jhep.2019.04.001","journal-title":"J Hepatol"},{"key":"2733_CR8","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.jhep.2011.11.021","volume":"56","author":"H Hayashi","year":"2012","unstructured":"Hayashi H, Mizuno T, Horikawa R et al (2012) 4-Phenylbutyrate modulates ubiquitination of hepatocanalicular MRP2 and reduces serum total bilirubin concentration. J Hepatol 56:1136\u20131144. https:\/\/doi.org\/10.1016\/j.jhep.2011.11.021","journal-title":"J Hepatol"},{"key":"2733_CR9","doi-asserted-by":"publisher","first-page":"5876","DOI":"10.1016\/j.bmcl.2011.07.095","volume":"21","author":"Y Jia","year":"2011","unstructured":"Jia Y, Bhuiyan MJ, Jun HJ et al (2011) Ursolic acid is a PPAR-alpha agonist that regulates hepatic lipid metabolism. Bioorg Med Chem Lett 21:5876\u20135880. https:\/\/doi.org\/10.1016\/j.bmcl.2011.07.095","journal-title":"Bioorg Med Chem Lett"},{"key":"2733_CR10","doi-asserted-by":"publisher","first-page":"105533","DOI":"10.1016\/j.tiv.2022.105533","volume":"87","author":"V KastrinouLampou","year":"2023","unstructured":"KastrinouLampou V, Poller B, Huth F et al (2023) Novel insights into bile acid detoxification via CYP, UGT and SULT enzymes. Toxicol In Vitro 87:105533. https:\/\/doi.org\/10.1016\/j.tiv.2022.105533","journal-title":"Toxicol In Vitro"},{"key":"2733_CR11","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.ejphar.2018.02.002","volume":"824","author":"Y Kong","year":"2018","unstructured":"Kong Y, Gao X, Wang C et al (2018) Protective effects of yangonin from an edible botanical Kava against lithocholic acid-induced cholestasis and hepatotoxicity. Eur J Pharmacol 824:64\u201371. https:\/\/doi.org\/10.1016\/j.ejphar.2018.02.002","journal-title":"Eur J Pharmacol"},{"key":"2733_CR12","doi-asserted-by":"publisher","first-page":"1890","DOI":"10.1002\/hep.29569","volume":"67","author":"KV Kowdley","year":"2018","unstructured":"Kowdley KV, Luketic V, Chapman R et al (2018) A randomized trial of obeticholic acid monotherapy in patients with primary biliary cholangitis. Hepatology 67:1890\u20131902. https:\/\/doi.org\/10.1002\/hep.29569","journal-title":"Hepatology"},{"key":"2733_CR13","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1111\/apt.16023","volume":"52","author":"KK Leung","year":"2020","unstructured":"Leung KK, Deeb M, Hirschfield GM (2020) Review article: pathophysiology and management of primary biliary cholangitis. Aliment Pharmacol Ther 52:1150\u20131164. https:\/\/doi.org\/10.1111\/apt.16023","journal-title":"Aliment Pharmacol Ther"},{"key":"2733_CR14","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.4268\/cjcmm20160725","volume":"41","author":"DD Li","year":"2016","unstructured":"Li DD, Tang XL, Tan HL et al (2016) 3D evaluation model for drug hepatotoxicity testing on HepG2 cells and its application in drug safety evaluation. Zhongguo Zhong Yao Za Zhi 41:1313\u20131317. https:\/\/doi.org\/10.4268\/cjcmm20160725","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"key":"2733_CR15","doi-asserted-by":"publisher","first-page":"154529","DOI":"10.1016\/j.phymed.2022.154529","volume":"108","author":"J Liu","year":"2023","unstructured":"Liu J, Liu J, Meng C et al (2023) NRF2 and FXR dual signaling pathways cooperatively regulate the effects of oleanolic acid on cholestatic liver injury. Phytomedicine 108:154529. https:\/\/doi.org\/10.1016\/j.phymed.2022.154529","journal-title":"Phytomedicine"},{"key":"2733_CR16","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1007\/s00204-016-1677-z","volume":"91","author":"C Luckert","year":"2017","unstructured":"Luckert C, Schulz C, Lehmann N et al (2017) Comparative analysis of 3D culture methods on human HepG2 cells. Arch Toxicol 91:393\u2013406. https:\/\/doi.org\/10.1007\/s00204-016-1677-z","journal-title":"Arch Toxicol"},{"key":"2733_CR17","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1002\/ptr.6621","volume":"34","author":"X Ma","year":"2020","unstructured":"Ma X, Jiang Y, Zhang W et al (2020) Natural products for the prevention and treatment of cholestasis: a review. Phytother Res 34:1291\u20131309. https:\/\/doi.org\/10.1002\/ptr.6621","journal-title":"Phytother Res"},{"key":"2733_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/pr.2015.252","volume":"79","author":"QQ Ou","year":"2016","unstructured":"Ou QQ, Qian XH, Li DY et al (2016) Yinzhihuang attenuates ANIT-induced intrahepatic cholestasis in rats through upregulation of Mrp2 and Bsep expressions. Pediatr Res 79:589\u2013595. https:\/\/doi.org\/10.1038\/pr.2015.252","journal-title":"Pediatr Res"},{"key":"2733_CR19","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/papr.12152","volume":"15","author":"JA Sastre","year":"2015","unstructured":"Sastre JA, Varela G, Lopez M et al (2015) Influence of uridine diphosphate-glucuronyltransferase 2B7 (UGT2B7) variants on postoperative buprenorphine analgesia. Pain Pract 15:22\u201330. https:\/\/doi.org\/10.1111\/papr.12152","journal-title":"Pain Pract"},{"key":"2733_CR20","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1142\/S0192415X21500191","volume":"49","author":"Y Shi","year":"2021","unstructured":"Shi Y, Leng Y, Liu D et al (2021) Research advances in protective effects of ursolic acid and oleanolic acid against gastrointestinal diseases. Am J Chin Med 49:413\u2013435. https:\/\/doi.org\/10.1142\/S0192415X21500191","journal-title":"Am J Chin Med"},{"key":"2733_CR21","doi-asserted-by":"publisher","unstructured":"Son J, Lee SY (2020) Therapeutic potential of ursonic acid: comparison with ursolic acid. Biomolecules 10. https:\/\/doi.org\/10.3390\/biom10111505","DOI":"10.3390\/biom10111505"},{"key":"2733_CR22","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1042\/CS20220674","volume":"137","author":"G Song","year":"2023","unstructured":"Song G, Weng F, Zou B et al (2023) Potential therapeutic action of tauroursodeoxycholic acid against cholestatic liver injury via hepatic Fxr\/Nrf2 and CHOP-DR5-caspase-8 pathway. Clin Sci (lond) 137:561\u2013577. https:\/\/doi.org\/10.1042\/CS20220674","journal-title":"Clin Sci (lond)"},{"key":"2733_CR23","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1146\/annurev-pharmtox-010818-021059","volume":"60","author":"M Wagner","year":"2020","unstructured":"Wagner M, Fickert P (2020) Drug therapies for chronic cholestatic liver diseases. Annu Rev Pharmacol Toxicol 60:503\u2013527. https:\/\/doi.org\/10.1146\/annurev-pharmtox-010818-021059","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"2733_CR24","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.jhep.2009.05.012","volume":"51","author":"M Wagner","year":"2009","unstructured":"Wagner M, Zollner G, Trauner M (2009) New molecular insights into the mechanisms of cholestasis. J Hepatol 51:565\u2013580. https:\/\/doi.org\/10.1016\/j.jhep.2009.05.012","journal-title":"J Hepatol"},{"key":"2733_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.jhep.2010.10.040","volume":"55","author":"X Wang","year":"2011","unstructured":"Wang X, Ikejima K, Kon K et al (2011) Ursolic acid ameliorates hepatic fibrosis in the rat by specific induction of apoptosis in hepatic stellate cells. J Hepatol 55:379\u2013387. https:\/\/doi.org\/10.1016\/j.jhep.2010.10.040","journal-title":"J Hepatol"},{"key":"2733_CR26","doi-asserted-by":"publisher","first-page":"115854","DOI":"10.1016\/j.jep.2022.115854","volume":"302","author":"D Xiang","year":"2023","unstructured":"Xiang D, Liu Y, Zu Y et al (2023) Calculus Bovis Sativus alleviates estrogen cholestasis-induced gut and liver injury in rats by regulating inflammation, oxidative stress, apoptosis, and bile acid profiles. J Ethnopharmacol 302:115854. https:\/\/doi.org\/10.1016\/j.jep.2022.115854","journal-title":"J Ethnopharmacol"},{"key":"2733_CR27","doi-asserted-by":"publisher","unstructured":"Xu LL, Su HX, Li PB et al (2023) Ursolic acid ameliorates myocardial ischaemia\/reperfusion injury by improving mitochondrial function via immunoproteasome-PP2A-AMPK signalling, Nutrients 15. https:\/\/doi.org\/10.3390\/nu15041049","DOI":"10.3390\/nu15041049"},{"key":"2733_CR28","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1038\/aps.2016.157","volume":"38","author":"ZZ Yang","year":"2017","unstructured":"Yang ZZ, Li L, Wang L et al (2017) The regioselective glucuronidation of morphine by dimerized human UGT2B7, 1A1, 1A9 and their allelic variants. Acta Pharmacol Sin 38:1184\u20131194. https:\/\/doi.org\/10.1038\/aps.2016.157","journal-title":"Acta Pharmacol Sin"},{"key":"2733_CR29","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1111\/liv.14262","volume":"40","author":"Y Yang","year":"2020","unstructured":"Yang Y, Liu L, Zhang X et al (2020) Tanshinone IIA prevents rifampicin-induced liver injury by regulating BSEP\/NTCP expression via epigenetic activation of NRF2. Liver Int 40:141\u2013154. https:\/\/doi.org\/10.1111\/liv.14262","journal-title":"Liver Int"},{"key":"2733_CR30","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2017.07.003","volume":"112","author":"W Zhang","year":"2017","unstructured":"Zhang W, Chen L, Feng H et al (2017) Rifampicin-induced injury in HepG2 cells is alleviated by TUDCA via increasing bile acid transporters expression and enhancing the Nrf2-mediated adaptive response. Free Radic Biol Med 112:24\u201335. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2017.07.003","journal-title":"Free Radic Biol Med"},{"key":"2733_CR31","doi-asserted-by":"publisher","first-page":"3981","DOI":"10.1021\/acs.jafc.2c06775","volume":"71","author":"H Zhao","year":"2023","unstructured":"Zhao H, Tang S, Tao Q et al (2023) Ursolic acid suppresses colorectal cancer by down-regulation of Wnt\/beta-catenin signaling pathway activity. J Agric Food Chem 71:3981\u20133993. https:\/\/doi.org\/10.1021\/acs.jafc.2c06775","journal-title":"J Agric Food Chem"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02733-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-023-02733-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-023-02733-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,12]],"date-time":"2024-03-12T17:26:21Z","timestamp":1710264381000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-023-02733-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,9]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["2733"],"URL":"https:\/\/doi.org\/10.1007\/s00210-023-02733-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3237167\/v1","asserted-by":"object"}]},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,9]]},"assertion":[{"value":"5 August 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experimental procedures were implemented in accordance with the Guide for the Care and Use of Laboratory Animals. All animal experiments were approved by the Ethics Committee of Nanchang University. (registration number: NCUSYDWFL-202016, date: 11\u201305-2020).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}